VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $252,000 | -23.6% | 17,911 | 0.0% | 0.00% | – |
| Q1 2019 | $330,000 | -9.8% | 17,911 | +28.0% | 0.00% | – |
| Q4 2018 | $366,000 | +102.2% | 13,995 | +17.6% | 0.00% | – |
| Q4 2017 | $181,000 | -15.0% | 11,896 | 0.0% | 0.00% | – |
| Q3 2017 | $213,000 | -48.6% | 11,896 | -53.1% | 0.00% | -100.0% |
| Q2 2017 | $414,000 | +16.6% | 25,373 | 0.0% | 0.00% | – |
| Q1 2017 | $355,000 | +59.2% | 25,373 | +81.6% | 0.00% | – |
| Q4 2016 | $223,000 | +25.3% | 13,973 | +12.6% | 0.00% | – |
| Q4 2014 | $178,000 | -61.3% | 12,413 | -72.0% | 0.00% | -100.0% |
| Q3 2014 | $460,000 | -35.8% | 44,313 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $717,000 | -40.8% | 44,313 | -40.5% | 0.00% | -50.0% |
| Q1 2014 | $1,211,000 | +30.9% | 74,513 | 0.0% | 0.00% | +33.3% |
| Q4 2013 | $925,000 | +140.3% | 74,513 | +112.3% | 0.00% | +200.0% |
| Q3 2013 | $385,000 | +220.8% | 35,100 | +135.6% | 0.00% | – |
| Q2 2013 | $120,000 | – | 14,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |